Search - Inria - Institut national de recherche en sciences et technologies du numérique Access content directly

Filter your results

58 Results
authFullName_s : David Pérol

A Personalized Physical Activity Program With Activity Trackers and a Mobile Phone App for Patients With Metastatic Breast Cancer: Protocol for a Single-Arm Feasibility Trial

Lidia Delrieu , Olivia Pérol , Béatrice Fervers , Christine M. Friedenreich , Jeff Vallance et al.
JMIR Research Protocols, 2018, 7 (8), ⟨10.2196/10487⟩
Journal articles hal-01882092v1

Is There a Role for Pelvic Irradiation in Localized Prostate Adenocarcinoma? Preliminary Results of GETUG-01

P. Pommier , Sylvie Chabaud , J.L. Lagrange , P. Richaud , F. Lesaunier et al.
Journal of Clinical Oncology, 2007, 25, pp.5366-5373
Journal articles hal-00434646v1
Image document

Chemotherapy for metastatic breast cancer. Comparison of clinical practice and cost of drugs in two cohorts of patients: 1994-1998 and 2003-2006

Guillaume Galy , Sana Intidhar Labidi-Galy , David Pérol , Thomas Bachelot , Isabelle Ray-Coquard et al.
Breast Cancer Research and Treatment, 2010, 128 (1), pp.187-195. ⟨10.1007/s10549-010-1311-3⟩
Journal articles hal-00615392v1

Prognostic factors of response or failure of treatment in patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Français d'Immunothérapie

S. Negrier , F. Gomez , J.-Y. Douillard , A. Ravaud , C. Chevreau et al.
World Journal of Urology, 2005, 23, pp.161-165
Journal articles hal-00427859v1

Radiotherapie avec blocage respiratoire pour les grands insuffisants respiratoires atteints d'un carcinome pulmonaire non a petites cellules (Protocole RESPI 2000) : application a la modelisation des deformations d'organes par recalage deformable

D. Sarrut , David Pérol , P. Pommier , C. Carrie
Cancer/Radiothérapie, 2006, 10 (6-7), pp.377--380
Journal articles hal-00443458v1

A cost analysis of complex radiotherapy for patients with head and neck cancer

Lionel Perrier , Magali Morelle , Pascal Pommier , Pierre Boisselier , Bernard Coche-Dequeant et al.
International Journal of Radiation Oncology, Biology, Physics, 2016, 95 (2), pp. 654-662 ⟨10.1016/j.ijrobp.2016.02.013⟩
Journal articles halshs-01300834v1

Toxicity and efficacy of cetuximab associated with several modalitiesof IMRT for locally advanced head and neck cancer

J-E Bibault , Magali Morelle , Lionel Perrier , Pascal Pommier , Pierre Boisselier et al.
Cancer/Radiothérapie, 2016, 20 (5), pp. 357-361. ⟨10.1016/j.canrad.2016.05.009⟩
Journal articles halshs-01366224v1

Pegfilgrastim versus Filgrastim after high-dose chemotherapy and autologous stem cell transplantation in adult patients with lymphoma and myeloma: cost-effectiveness evaluation alongside a randomized controlled trial

Lionel Perrier , Anne Lefranc , Philippe Quittet , Hervé Ghesquières , Bertrand Favier et al.
8th World congress on Health Economics, International Health Economics Association, Toronto, Canada, 10-13 juillet 2011, Jul 2011, Toronto, Canada
Conference papers halshs-00628854v1

Connected device and therapeutic patient education to promote physical activity among women with localised breast cancer (DISCO trial): protocol for a multicentre 2×2 factorial randomised controlled trial

Marina Touillaud , Baptiste Fournier , Olivia Pérol , Lidia Delrieu , Aurélia Maire et al.
Journal articles halshs-03428061v1

Cost-effectiveness of an exercise and nutritional intervention versus usual nutritional care during adjuvant treatment for localized breast cancer: the PASAPAS randomized controlled trial

Lionel Perrier , Aude-Marie Foucaut , Magali Morelle , Marina S. Touillaud , Anne-Sophie Kempf-Lépine et al.
Supportive Care in Cancer, 2020, 28, pp. 2829-2842. ⟨10.1007/s00520-019-05078-4⟩
Journal articles halshs-02378666v1

Interleukin-6 Interleukin-10 and Vascular Endothelial Growth Factor in Metastatic Renal Cell Carcinoma: Prognostic Value of Interleukin-6--From the Groupe Français d'Immunothérapie

S. Negrier , David Pérol , C. Menetrier-Caux , B. Escudier , M. Pallardy et al.
Journal of Clinical Oncology, 2004, 22(12), pp.2371-2378
Journal articles hal-00698385v1

Pazopanib plus best supportive care versus best supportive care alone in advanced gastrointestinal stromal tumours resistant to imatinib and sunitinib (PAZOGIST): a randomised, multicentre, open-label phase 2 trial

Olivier Mir , Claire Cropet , Maud Toulmonde , Axel Le Cesne , Mathieu Molimard et al.
Lancet Oncology, 2016, 17 (5), pp.632-641. ⟨10.1016/s1470-2045(16)00075-9⟩
Journal articles hal-03623734v1

Routine molecular screening of advanced refractory cancer patients: An analysis of the first 2490 patients of the ProfiLER study.

Olivier Tredan , Veronique Corset , Qing Wang , Romain Varnier , Camille Pacaud et al.
Journal of Clinical Oncology, 2017, 35 (18_suppl), pp.LBA100-LBA100. ⟨10.1200/JCO.2017.35.18_suppl.LBA100⟩
Journal articles hal-03811696v1

Design and methods of a national, multicenter, randomized and controlled trial to assess the efficacy of a physical activity program to improve health-related quality of life and reduce fatigue in women with metastatic breast cancer: ABLE02 trial

Lidia Delrieu , Amélie Anota , Olivier Trédan , Damien Freyssenet , Aurélia Maire et al.
BMC Cancer, 2020, 20 (1), pp.622. ⟨10.1186/s12885-020-07093-9⟩
Journal articles hal-03869935v1

Radioresistance and genomic alterations in head and neck squamous cell cancer: Sub‐analysis of the ProfiLER protocol

Elise Rowinski , Nicolas Magné , Jérôme Fayette , Elisabeth Daguenet , Séverine Racadot et al.
Head & Neck, 2021, 43 (12), pp.3899-3910. ⟨10.1002/hed.26891⟩
Journal articles hal-03461669v1

A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer : clinical and dosimetric factors analysis

Line Claude , David Pérol , Chantal Ginestet , Lionel Falchero , Dominique Arpin et al.
Radiotherapy & Oncology, 2004, 71 (2), pp.175-181. ⟨10.1016/j.radonc.2004.02.005⟩
Journal articles istex hal-02678297v1

Proof-of-concept study evaluating a new tool for standardizing radiological assessment of tumor response to treatment in routine clinical practice.

Charles Mastier , Christelle de La Fouchardiere , Pierre-Étienne Heudel , Jérome Fayette , Matthieu Sarabi et al.
Journal of Clinical Oncology, 2019, 37 (15_suppl), pp.e18079-e18079. ⟨10.1200/JCO.2019.37.15_suppl.e18079⟩
Journal articles hal-02163278v1

Feasibility and health benefits of an individualized physical activity intervention in women with metastatic breast cancer: results of the ABLE single-arm Trial study

Lidia Delrieu , Vincent Pialoux , Olivia Pérol , Magali Morelle , Agnès Martin et al.
JMIR mHealth and uHealth, 2020, 8 (1), pp.e12306. ⟨10.2196/12306⟩
Journal articles halshs-02389100v1
Image document

Alterations in Homologous Recombination-Related Genes and Distinct Platinum Response in Metastatic Triple-Negative Breast Cancers: A Subgroup Analysis of the ProfiLER-01 Trial

Elise Bonnet , Véronique Haddad , Stanislas Quesada , Kim-Arthur Baffert , Audrey Lardy-Cléaud et al.
Journal of Personalized Medicine, 2022, 12, pp.1595. ⟨10.3390/jpm12101595⟩
Journal articles hal-03915443v1
Image document

Molecular profile to guide personalized medicine in adult patients with primary brain tumors: results from the ProfiLER trial

Alice Bonneville-Levard , Didier Frappaz , Olivier Tredan , Emilie Lavergne , Véronique Corset et al.
Medical Oncology, 2021, 39 (1), pp.4. ⟨10.1007/s12032-021-01536-4⟩
Journal articles hal-03915456v1

Imatinib rechallenge in patients with advanced gastrointestinal stromal tumors.

Jean-Yves Blay , David Pérol , A. Le Cesne
Annals of Oncology, 2012, 23 (7), pp.1659-65. ⟨10.1093/annonc/mdr622⟩
Journal articles hal-00860391v1

Neoadjuvant imatinib in patients with locally advanced non metastatic GIST in the prospective BFR14 trial.

Aurore Blesius , Philippe A Cassier , François Bertucci , Jérome Fayette , Isabelle Ray-Coquard et al.
BMC Cancer, 2011, 11, pp.72. ⟨10.1186/1471-2407-11-72⟩
Journal articles hal-00779604v1

Lymphopenia combined with low TCR diversity (divpenia) predicts poor overall survival in metastatic breast cancer patients.

Manuarii Manuel , Olivier Tredan , Thomas Bachelot , Gilles Clapisson , Anais Courtier et al.
OncoImmunology, 2012, 1 (4), pp.432-440
Journal articles hal-00724448v1

Revisiting the level of evidence in randomized controlled clinical trials: A simulation approach

A. Bajard , Sylvie Chabaud , David Pérol , J.-P. Boissel , Patrice Nony et al.
Contemporary Clinical Trials, 2009, 30(5), pp.400-410
Journal articles hal-00539401v1
Image document

The effect of health care expenditures on survival in locally advanced and metastatic Non Small Cell Lung Cancer

Lionel Perrier , Magali Morelle , Nathalie Havet , Anthony Montella , Bertrand Favier et al.
Other publications halshs-00371825v1

Contemporary outcomes of metastatic breast cancer among 22,000 women from the multicentre ESME cohort 2008–2016

Elise Deluche , Alison Antoine , Thomas Bachelot , Audrey Lardy-Cleaud , Véronique Dieras et al.
European Journal of Cancer, 2020, 129, pp.60-70. ⟨10.1016/j.ejca.2020.01.016⟩
Journal articles hal-02887991v1

Hyperprogressive Disease After Combined Anti-PD-L1 and Anti-CTLA-4 Immunotherapy for MSI-H/dMMR Gastric Cancer: A Case Report

Romain Varnier , Thibaut Garrivier , Emilie Hafliger , Aymeric Favre , Clélia Coutzac et al.
Frontiers in Oncology, 2021, 11, ⟨10.3389/fonc.2021.756365⟩
Journal articles hal-03811683v1

Cost-effectiveness of Pegfilgrastim versus Filgrastim after high-dose chemotherapy and autologous stem cell transplantation in patients with lymphoma and myeloma

Lionel Perrier , Anne Lefranc , Philippe Quittet , Philippe Moreau , Carole Siani et al.
Applied Health Economics and Health Policy, 2013, 11 (2), pp. 129-138. ⟨10.1007/s40258-013-0011-7⟩
Journal articles halshs-00752571v1
Image document

Coût du programme d’éducation thérapeutique « Mieux manger, mieux bouger à l’aide de l’éducation nutritionnelle » chez les patientes atteintes d’un cancer du sein

Mariam El Khal , Lionel Perrier , Julien Carretier , Marina Touillaud , Magalie Hureau et al.
Bulletin du Cancer, 2020, 107 (12), pp.1252-1259. ⟨10.1016/j.bulcan.2020.07.003⟩
Journal articles halshs-03428053v1

Cost-effectiveness of Pegfilgrastim versus Filgrastim after high-dose chemotherapy and autologous stem cell transplantation in patients with lymphoma and myeloma

Lionel Perrier , Anne Lefranc , Philippe Quittet , Philippe Moreau , Carole Siani et al.
16th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Baltimore, Etats-Unis, 25 mai 2011, May 2011, Baltimore, United States
Conference papers halshs-00628829v1